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Genome-wide association and ﬁne-mapping studies in 14 autoimmune diseases (AID) have implicated
more than 250 loci in one or more of these diseases. As more than 90% of AID-associated SNPs are
intergenic or intronic, pinpointing the causal genes is challenging. We performed a systematic analysis to
link 460 SNPs that are associated with 14 AID to causal genes using transcriptomic data from 629 blood
samples. We were able to link 71 (39%) of the AID-SNPs to two or more nearby genes, providing evidence
that for part of the AID loci multiple causal genes exist. While 54 of the AID loci are shared by one or
more AID, 17% of them do not share candidate causal genes. In addition to ﬁnding novel genes such as
ULK3, we also implicate novel disease mechanisms and pathways like autophagy in celiac disease
pathogenesis. Furthermore, 42 of the AID SNPs speciﬁcally affected the expression of 53 non-coding RNA
genes. To further understand how the non-coding genome contributes to AID, the SNPs were linked to
functional regulatory elements, which suggest a model where AID genes are regulated by network of
chromatin looping/non-coding RNAs interactions. The looping model also explains how a causal
candidate gene is not necessarily the gene closest to the AID SNP, which was the case in nearly 50% of
cases.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The genetic basis for autoimmune diseases (AID) has been
successfully demonstrated by GWAS, which have now ﬁrmly
associated more than 250 loci to 14 common AID [1]. Some of these, University Medical Centre
etherlands.
Ltd. This is an open access article uloci are also shared by more than one AIDs. Fine-mapping studies
have drastically reﬁned the regions of association and revealed that
more than 90% of the AID-associated SNPs are found in non-coding
regions (summarized by Rica~no-Ponce & Wijmenga) [2]. These
studies have further shown that more than 40% of AID-associated
SNPs affect the expression levels of nearby protein-coding genes
(cis-eQTLs) [2,3] and sometimes those of genes located elsewhere
in the genome (trans-eQTLs) [4]. These studies indicate that caus-
ative genes can be located outside the peak of association and that
ﬁne-mapping merely points towards the location of the causal
variants. Moreover, eQTL studies have focused on the protein-nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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man genome transcribed into non-coding RNAs (ncRNAs) [5]. To
date, only a few ncRNAs have been implicated in diseases, but this
mostly seems to reﬂect the difﬁculty of studying them. Although
the function of the majority of ncRNAs is unknown, it has become
clear that they are important regulators of gene expression. In a
proof-of-concept study, we recently showed that disease-
associated SNPs can also impact the expression of ncRNAs [6]. By
annotating GWAS loci with ncRNA transcripts, we demonstrated
that ncRNAs can physically overlap AID-SNPs [2]. These two ob-
servations led us to hypothesize that ncRNAs might be crucial
regulators in AIDs by affecting the expression levels of protein-
coding genes, either in cis or in trans, thereby providing a link be-
tween non-coding AID-SNPs and protein-coding genes.
In this study we performed cis-eQTL analysis on AID-SNPs using
RNA-sequencing data from peripheral blood mononuclear cells
(PBMCs) from 629 healthy individuals. We identiﬁed cis-eQTL effect
on 233 genes, including 53 ncRNAs. We found that the regulation is
rather more complex than a single SNP affecting the closest gene, as
we observed that half of the SNPs affect more than one gene and
that in more than 50% of the loci, the gene closest to the AID-SNP
was not the candidate causal gene. Moreover, some of the loci
shared by AID do not share causal SNPs or candidate causal genes,
further contributing to the complexities of AID genetic architecture.
2. Materials and methods
2.1. Ethical statement and study cohorts
The study procedures were approved by the authorities in all
the participating centres and the studies were conducted according
to Dutch rules for approval by ethics committee and for gaining
informed consent. Participants of the LifeLines Deep population
cohort were enrolled after giving informed consent, following an
institutional review board protocol approved by the University
Medical Centre Groningen (Groningen, the Netherlands). The Rot-
terdam Study (Rotterdam cohort) was approved by the medical
ethics committee according to the Dutch Population Screening Act,
Rotterdam Study, as executed by the Netherlands Ministry of
Health, Welfare and Sports. Written informed consent was ob-
tained from all the participants. Blood samples for DNA isolation
and subsequent genotyping analysis were collected in EDTA
Vacutainer® tubes (BD Biosciences, San Jose, CA, USA). Blood sam-
ples for RNA isolation and subsequent RNA-seq analysis were
collected in PAXgene tubes (PAXgene Blood RNATube, PreAnalytix
GmbH, Switzerland, ref 762165). Peripheral blood mononuclear
cells (PBMCs) were isolated using 2ml of whole blood with EDTA in
a cell preparation tube (CPT) containing Heparin (BD Vacutainer
CPT, ref 362780), according to the manufacturer's instructions.
2.2. SNPs associated to autoimmune diseases
We collected data on 14 different AID phenotypes
(Supplemental Table 1) previously genotyped by Immunochip
analysis [as of February 2014] in 15 different studies (including two
studies on rheumatoid arthritis). In total, we extracted 543 SNPs
that showed signiﬁcant association (P < 5  108) to any of the 14
AID (referred to as AID-SNPs); 35 SNPs are shared by at least two
diseases, yielding 508 unique SNPs. After applying SNP genotype
quality control ﬁlters, we obtained a ﬁnal set of 460 different AID-
SNPs for cis-eQTL mapping (Supplemental Table 2).
2.3. Genotyping and genotype imputation
DNA isolation was performed by the Qiagen robots usingAutopure LS kits. Genotyping of DNA from the LifeLines Deep
cohort was performed using both the HumanCytoSNP-12 BeadChip
and the ImmunoChip platforms (Illumina, San Diego, CA, USA).
First, SNP quality control was applied independently for both
platforms. SNPs were ﬁltered on MAF above 0.001, a Hardy-
Weinberg equivalent P value >1e4 and a call rate of >0.98 using
Plink [7]. Genotyping of the Rotterdam samples was performed
with the Inﬁnium II HumanHap 550K þ 610K Quad Genotyping
GenomeStudio® (Illumina). Polymorphisms were genotyped ac-
cording to the manufacturer's instructions. Quality controls and the
results of the genotyping have been published elsewhere [8].
The genotypes from both platforms were merged into one
dataset. After merging, SNPs were again ﬁltered on MAF 0.05 and a
call rate of 0.98, resulting in a total of 379,885 genotyped SNPs.
Next, this data was imputed based on the Genome of the
Netherlands (GoNL) reference panel [9e11]. The merged genotypes
were pre-phased using SHAPEIT2 [12] and aligned to the GoNL
reference panel using Genotype Harmonizer [13] (http://www.
molgenis.org/systemsgenetics/) in order to resolve strand issues.
Imputation was performed using IMPUTE2 [14] version 2.3.0
against the GoNL reference panel. We used the MOLGENIS compute
imputation pipeline to generate our scripts and monitor the
imputation [15].
2.4. RNA isolation and library preparation
RNA from PBMCswas extracted using the PAXgene BloodmiRNA
Kit (Qiagen) according to the manufacturer's instructions. RNA
quantity and quality were determined using the Nanodrop 1000
spectrometer (Thermo Fisher Scientiﬁc, Landsmeer, the
Netherlands) and the Expirion High-sensitivity RNA analysis kit
(Bio-Rad, Waltham, MA, USA), respectively. Total RNA from whole
blood was deprived of globin using Ambion's GLOBINclear kit.
RNAseq libraries were prepared from 1 mg RNA of each cell popu-
lation using the TruSeq RNA sample preparation kit v2 (Illumina)
according to the manufacturer's instructions, and these libraries
were subsequently sequenced on a HiSeq 2000 sequencer (Illu-
mina) using paired-end sequencing of 2 50 bp, upon pooling of 10
samples per lane. Finally, read sets per sample were generated
using CASAVA, retaining only reads passing Illumina's Chastity
Filter for further processing.
2.5. Analysis of RNAseq reads
The sequencing reads from the LifeLines Deep data were map-
ped to human reference genome NCBI build 37 using STAR v2.3.1
[16], allowing for eight mismatches and ﬁve mapping positions. To
reduce reference mapping bias, GoNL SNPs with MAF >1% were
masked by “N”. On average, 92% of the reads weremapped, and 88%
of all reads were mapped uniquely. In total, 88% of all aligned reads
were mapping to exons.
Gene expression was estimated using HTSeq count [17] using
Ensembl GRCh37.71 gene annotation. Only uniquely mapping reads
were used for estimating expression. Before eQTL mapping, gene
expression datawas TMM (trimmedmean of M values), normalized
[18] and log2-transformed. The expression of each gene was cen-
tred and scaled. To reduce the effect of non-genetic sources of
variability, we applied principal component analysis on the sample
correlation matrix and the ﬁrst ﬁve components were used as
covariates [19].
2.6. Cis- and trans-eQTL mapping
As a discovery set, 629 peripheral blood samples from the
LifeLines Deep cohort were investigated to map cis-eQTLs. For
I. Rica~no-Ponce et al. / Journal of Autoimmunity 68 (2016) 62e7464trans-eQTL analysis, we performed a meta-analysis with 456 hae-
matological samples downloaded from public databases (https://
www.ebi.ac.uk/arrayexpress/) [20]. The eQTL mapping strategy
data has been described in detail previously [19,21]. Brieﬂy, cis-
eQTL analysis was performed on transcript-SNP combinations for
which the distance from the centre of the transcript to the genomic
location of the SNP was 250 kb, whereas eQTLs with a distance
greater than 5 Mb were deﬁned as trans-eQTLs. Associations were
tested by non-parametric Spearman's rank correlation test and the
FDR signiﬁcance thresholds (P < 0.05; Supplemental Table 1) were
deﬁned based on the number of SNPs associated to each disease.
We categorized the SNPs as follows: (1) SNPs showing primary
effect where the index SNP is same as the SNP showing the
strongest eQTL effect, or is a different SNP but in perfect LD (D’ ¼ 1)
or in high LD (r2  0.8). (2) SNPs showing secondary effect where
the index SNP and SNP showing the strongest eQTL effect show
differences in allele frequency resulting in low D0 values and r2
values <0.8, but after conditioning on the eQTL SNP, the eQTL effect
of index SNP is still signiﬁcant. We excluded SNPs where the index
SNP and SNP showing the strongest eQTL affect show differences in
allele frequency resulting in low D0 values and r2 values <0.8 and
where, after conditioning on the eQTL SNP, the eQTL effect is gone
(n ¼ 237).
An additional cis-eQTL mapping was performed to include all
the SNPs, extending the mapping distance to 1 Mb up- and
downstream.
2.7. Replication cohort
The cis-eQTL results were replicated in the Rotterdam cohort,
comprising 651 PBMCs samples. RNA-seq data was obtained in the
same way as LifeLines Deep samples. The adaptors identiﬁed by
FastQC (v0.10.1) were clipped using cutadapt (v1.1) applying
default settings. Sickle (v1.200) was used to trim low quality ends
of the reads (minimum length 25, minimum quality 20). The
sequencing reads were mapped to human reference genome NCBI
build 37 using STAR v2.3.1 [16], allowing for eight mismatches and
ﬁve mapping positions. To reduce reference mapping bias, GoNL
SNPs with MAF >1% in the reference genome were masked by “N”.
Ensembl GRCh37.71 was used for gene annotation. The overlapping
exons were merged into meta-exons and gene expression was
calculated as the sum of expression values of all meta-exons of
each gene. To do this, custom scripts were developed which use
coverage per base from coverageBed, and intersectBed from the
Bedtools suite (v2.17.0) [22] and R (v2.15.1). Before the eQTL anal-
ysis, the data was normalized as for LifeLines Deep and corrected
for the ﬁrst 25 principal components. In the replication set, P
values <0.05 were considered to indicate signiﬁcant eQTLs, but
only if the direction of the effect was the same as in the LifeLines
Deep data.
2.8. Expression data from seven cell types
We used the expression data generated from immune cell
subsets from two individuals. These immune cell subsets were
granulocytes, monocytes, NK cells, B cells, memory T-cells (both
CD4þ and CD8þ), naive CD4þ (T-helper cells) and naive CD8þ
(cytotoxic T-cells). These datasets has been described previously
[23].
2.9. Analysis of autophagy genes expression data in coeliac disease
biopsies
Intestinal biopsies from 31 coeliac disease (CeD) patients and 12
healthy controls were investigated according to the UnitedEuropean Gastroenterology (UEG) criteria. Biopsy sampling, RNA
isolation, details of microarray hybridization and data analyses have
been described previously [24,25]. DNA from the 31 patients was
genotyped using the Immunochip platform [26] and the genotype
data at ULK3 SNP was extracted. A list of 222 autophagy genes was
extracted from Human Autophagy Database (HADb; http://
autophagy.lu/clustering/index.html) and, for 217 of these genes,
we could extract their expression data from biopsies. In total, we
found 1155 out of 28,000 genes showing signiﬁcant differential
expression between the CeD biopsies and controls (P< 0.05). Among
these, nearly 50% of autophagy genes (107 genes out of 217) showed
differential expression. A Fisher exact test indicated that autophagy
genes are more enriched in differentially expressed genes
(P < 2.2  1016) than non-autophagy genes. In addition, a 1000
times random sampling of genes from the same dataset produced a
similar result (KolmogoroveSmirnov test; P ¼ 0.002), suggesting
enrichment of autophagy genes within the differentially expressed
genes in the CeD biopsies. To correlate the expression data with
genotypes, the normalized expression values were stratiﬁed ac-
cording to the genotypes. The signiﬁcant differences were tested
using the t-test and P values <0.05 were considered signiﬁcant.2.10. Cytokine analysis
Cytokines from Candida albicans and LPS stimulation in human
PBMCs were measured using an enzyme-linked immunosorbent
assay (R&D Systems, Minneapolis, MN, USA), as previously
described [27,28]. The cytokine levels were log-transformed and
the correlation between cytokine production and genotypes was
tested by a linear regression model, which included age and
gender as co-variables. P values <0.05 were considered
signiﬁcant.2.11. Size of the linkage disequilibrium blocks, transcription factor-
and super enhancer enrichment analyses
The enrichment analysis was done to test whether there is any
signiﬁcant difference in the sizes of the LD block, type of tran-
scription factor (TF) binding, or number of super enhancers
encompassed in single-gene SNP and multi-gene SNP regions.
Initial cis-eQTL mapping within a 500 kb cis-window identiﬁed 112
single-gene SNP and 71 multi-gene SNP regions. The size of the LD
blocks for these regions was deﬁned based on the location of their
proxy SNPs (r2  0.8; extracted using the CEU population in 1000
Genomes data). The difference in the size of the LD blocks between
these two groups was calculated using the Wilcoxon Rank test and
P values < 0.05 were considered signiﬁcant.
Upon cis-eQTL mapping in a 2 Mb extended window, we ob-
tained 90 single-gene SNP regions and 92 multi-gene SNP regions.
The super enhancers within 86 cell lines were extracted from a
published source [29]. (See Supplemental Table 3 for more detailed
information about the cell lines.) The 90 single-gene SNP regions
and 92 multi-gene SNP regions were intersected with the chro-
mosomal coordinates of these super enhancers. The signiﬁcant
difference was tested by the Fisher Exact test and a P value of <0.05
was considered signiﬁcant.
We extracted transcription factor (TF) binding data from ChIP-
seq experiments using RegulomeDB (http://regulomedb.org/).
These regions were intersected with gSNPs and their proxies
(r2  0.8). We calculated the number of binding events per TF in
each loci. The difference in the number of binding events per TF
between multi-gene SNP and single-gene SNP regions was calcu-
lated using the Fisher Exact test and P values <0.05 were consid-
ered signiﬁcant.
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The DNase I hypersensitive sites from different cell lines were
extracted from the BluePrint epigenome project (http://www.
blueprint-epigenome.eu/index.cfm?p¼B5E93EE0-09E2-5736-
A708817C27EF2DB7) and the ENCODE data from the UCSC browser
(http://ucscbrowser.genap.ca/cgi-bin/hgTrackUi?
g¼wgEncodeAwgDnaseUniform). These regions were intersected
with gSNPs and their proxies (r2  0.8). See Supplemental Table 4
for more information about the cell lines.
2.13. RNA network for gene function and pathway prediction
The RNA network is an extension of the gene network [6,30] and
was built to generate functional predictions for non-coding RNA
genes. The gene network database contains data extracted from
approximately 80,000 microarray experiments that are publically
available from the Gene Expression Omnibus. It contains data on
54,736 human, 17,081 mouse and 6023 rat Affymetrix array ex-
periments. Principal component analysis was performed on probe-
set correlation matrices of each of four platforms (two human
platforms, one mouse and one rat platform), resulting in 777, 377,
677 and 375 robust principal components, respectively. Jointly
these components explain between 79% and 90% of the variance in
the data, depending on the species or platform. Many of these
components are well conserved across species and enriched for
known biological phenomena. This meant wewere able to combine
the results into a multi-species gene network with 19,997 unique
human genes, allowing us to utilize the principal components to
accurately predict gene function by using a ‘guilt-by-association’
procedure. Pathway prediction for each gene was performed as
described by Fehrmann et al [7]. Prediction was based on the 5000
RNA-seq samples, using the Gene Ontology Biological Processes
gene set for pathway deﬁnition. The resulting geneepathway as-
sociation Z-scores was compared between selected genes and all
the other genes in the genome using ManneWhitney U tests. The
resulting P values therefore describe the predicted enrichment of
each Gene Ontology term for the selected genes (manuscript in
preparation). The most signiﬁcant top-ﬁve terms are reported in
the ﬁgures.
2.14. CHIA-PET analysis
The RNAPII mediated interactions were identiﬁed by ChIA-PET
in GM12878 cells with stringent quality ﬁltering. The ChIA-PET
experimental and informatics protocols used to elucidate these
chromatin interactions have been previously described [31,32]. The
full dataset is published elsewhere [33].
3. Results
3.1. RNAseq based eQTL-mapping identiﬁes 233 causal AID genes
including 53 non-coding RNA genes
To systematically examine the effect of AID-SNPs on the
expression of both protein-coding and ncRNA genes, we used RNA-
sequencing data from PBMCs from 629 healthy individuals. We
performed conditional cis-eQTL mapping on a ﬁnal set of 460
unique SNPs encompassing 268 loci (deﬁned as 1 Mb region
around the index SNPs), which have been associated to 14
different AIDs (Supplemental Fig. 1, Supplemental Table 2). By
mapping the cis-eQTLs at 460 AID SNPs, we identiﬁed 183 SNPs as
cis-eQTLs (40%) that were correlated with the expression of 233
different transcripts (resulting in 326 SNP-gene pairs). Replication
(P < 0.05) in the same direction was achieved for 84% of the SNP-gene pairs in independent RNA-sequencing data (651 PBMCs)
(Supplemental Fig. 2). Our cis-eQTL mapping implicated 63 SNPs
that affect the expression of 53 ncRNAs, and 157 SNPs that affect
the expression of 180 protein-coding genes (Supplemental
Table 5). Of these, 112 were associated to the expression levels of
single genes (i.e. 87 AID-SNPs were associated to 68 protein-
coding genes, and 25 AID-SNPs to 22 ncRNAs), while the other
71 AID cis-eQTL SNPs affect the expression levels of two to seven
different genes in a 500 Kb region (Fig. 1A). The percentage of cis-
eQTLs observed for each AID varied from 25% for juvenile idio-
pathic arthritis to almost 70% for primary sclerosing cholangitis
(Fig. 1B). To reveal the regulatory consequences of the eQTL SNPs
on downstream pathways and cellular phenotypes, we investi-
gated the expression-speciﬁcity of the eQTL-affected genes across
seven different immune cell types (Supplemental Fig. 1) and pre-
dicted the gene function using co-expression analysis [30]. This
was particularly necessary for the ncRNA genes since their mo-
lecular functions are largely unknown.
3.2. Integrative genomic analyses implicate novel genes for AIDs
and implicate autophagy in celiac disease
Our cis-eQTL mapping revealed novel candidate genes in several
loci, of which GPR25 (G protein-coupled receptor 25; associated
with ankylosing spondylitis (AS), coeliac disease (CeD), inﬂamma-
tory bowel disease (IBD), multiple sclerosis (MS) locus on 1q32.1)
and ULK3 (unc-51-like kinase 3; CeD locus on 15q24.1) are exam-
ples (Fig. 2A, B). Previously, C1orf106 was implicated as a causal
gene for IBD at 1q32.1 [34]. While the expression level of C1orf106
was moderately correlated with four disease-associated SNPs, our
analysis unequivocally identiﬁed GPR25 as the most signiﬁcantly
affected gene in this locus (Fig. 2A). We found GPR25 to be strongly
expressed in memory T-cells and NK-cells, and predicted to be
involved in the positive regulation of B-cell proliferation
(P¼ 1.21 106). Nonetheless, C1orf106 is suggested to be involved
in epithelial cellecell adhesion [35], an essential process in keeping
the intestinal epithelial-barrier intact in the context of IBD and CeD.
Therefore, it is possible that both genes in this locus contribute to
disease through different cell types. A similar observation was
made for the CeD locus on 15q24 (Fig. 2B). The expression level of
ULK3 is much more strongly affected by rs1378938
(P ¼ 1.21  1046) than CSK (P ¼ 7.08  106). CSK is involved in B-
cell activation [36] and ULK3 encodes a kinase involved in auto-
phagy [37]. However, the autophagy pathway has never been
implicated in CeD, which highlights the possibility of identifying
novel pathways underlying CeD.
3.3. Studying patient biomaterials validated the functional role of
ULK3 locus in autophagy in celiac disease
To investigate the functional impact of ULK3 locus on auto-
phagy pathway in CeD, we tested whether known autophagy
genes were differentially regulated in intestinal biopsies of CeD
patients [35]. We indeed observed an enrichment of autophagy
genes being differentially expressed (Fig. 3A) compared to a
random set of genes in CeD biopsies (P ¼ 2.2  1016). We further
conﬁrmed that the ULK3 affecting SNP genotype is correlated with
the expression levels of autophagy genes in CeD biopsies
(Supplemental Fig. 3). Autophagy is also involved in regulating
inﬂammatory process in response to human pathogens by inﬂu-
encing cytokine production and secretion. We therefore tested
whether ULK3 SNP inﬂuences the production of cytokines in
PBMCs in response to lipopolysaccharide (LPS), a cell-wall
component of Gram negative bacteria. We found a signiﬁcant
difference (P ¼ 0.019) in the levels of IL-6 between rs1378938 CC
Fig. 1. Break down of cis-eQTLs into coding and non-coding genes. (A) The pie-chart summarizes the cis-eQTLs we identiﬁed in which, 112 out of 183 cis-eQTL AID-SNPs were
associated to single genes (i.e. 87 AID-SNPs to 68 protein-coding genes and 25 AID-SNPs to 22 ncRNAs), while the other 71 AID cis-eQTL SNPs affected the expression levels of two to
seven different genes within the 500 kb region (see Supplemental Table 2). (B) The cis-eQTL mapping results per disease are shown to indicate the number of SNPs remaining for
eQTL mapping (shown on top of the purple bars) as well as the number of SNPs that showed signiﬁcant cis-eQTLs (shown on top of the orange bars). Because of the wide range in
the number of SNPs associated to each of the AIDs, we deﬁned false discovery rate (FDR) signiﬁcance thresholds for each disease separately to assist in the eQTL analysis (see
Methods). *These loci are shared between ulcerative colitis (UC) and Crohn's disease (CD). The non-shared loci are listed separately. Alopecia areata (AA), atopic dermatitis (AD),
ankylosing spondylitis (AS), autoimmune thyroid disease (ATD), coeliac disease (CeD), inﬂammatory bowel disease (IBD), juvenile idiopathic arthritis (JIA), multiple sclerosis (MS),
primary biliary cirrhosis (PBC), psoriasis (PS), rheumatoid arthritis (RA), primary sclerosing cholangitis (PSCh), and systemic sclerosis (SS).
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levels of IL-6 in response to LPS (Fig. 3B). This ﬁnding indicated
that ULK3 dependent autophagy might be involved in regulation of
inﬂammation and emphasizes the importance of studying non-
gluten antigens (e.g. hostemicrobiome interaction) in the context
of CeD pathogenesis.
3.4. AID-associated lncRNAs are involved in immune cell activation
and cytokine regulation
Our study identiﬁed 27 ncRNAs at 25 AID-loci as candidate
causal genes as these were the only affected transcripts in PBMCs
(Table 1). Although previous microarray-based eQTL studies sug-
gested UBE2E3 as the causal gene at 2q31.3, a locus associated with
CeD and AS [35], our analysis indicates that the AS (rs12615545)-and CeD (rs1018326)-associated SNPs are not in LD with the eQTL
SNP that affects UBE2E3 expression (r2 ¼ 0.16). Instead, both the
AD and CeD index SNPs (r2 ¼ 0.94) affect the expression of long
non-coding RNA (lncRNA) AC104820.2 (P ¼ 9.22  108).
AC104820.2 is strongly expressed in CD8þ T-cells (Fig. 4A) and is
suggested to function in alpha-beta T-cell proliferation
(P ¼ 4.1  106), which is a crucial process in autoimmunity [38].
AC104820.2 was also found to be up-regulated in intestinal bi-
opsies of patients with active CeD [39]. Another example is lncRNA
AP002954.4 at 11q23.3, whose expression was signiﬁcantly
affected by three unrelated SNPs associated to three different AIDs
(MS, RA and CeD). AP002954.4 is expressed speciﬁcally in mono-
cytes and may function in regulating cytokine responses
(P ¼ 5.95  106) and defence against fungal infection
(P¼ 3.79  105) (Fig. 4B). Indeed, the cytokine levels produced by
Fig. 2. Cis-eQTL identiﬁes novel candidate causal genes for AID. The top panel is a locus plot to show the location of all the genes tested in a 500 kb cis-window (hg19). The plot
centred below indicates the correlation between the expression of eQTL-genes with genotypes of AID-SNPs. The risk genotypes are in red. The expression pattern for eQTL-genes
across seven different immune cell types were obtained from two individuals and the average expression levels are shown as a heatmap in the lowest panel. (A) An example of
different AID-SNPs affecting the same genes and thus representing a truly shared locus. Four different SNPs at 1q32.1 show association to four different diseases (MS, IBD, AS and
CeD). All four SNPs are in absolute LD (r2 ¼ 1, D’ ¼ 1) and affect two protein-coding genes. The MS-associated risk allele rs55838263*T is associated with lower expression of both
GPR25 (P ¼ 3.02  1016) and C1ORF106 (P ¼ 0.0012) genes. The risk alleles for the other three SNPs show similar results. (B) Example of a cis-eQTL identifying novel candidate genes
and novel pathways. The CeD-associated risk allele, rs1378938*T is associated with a higher expression of both CSK (P ¼ 7.08  106) and ULK3 (P ¼ 1.21  1046). ULK3 encodes a
kinase involved in autophagy. This pathway has not been implicated in CeD so far. We found an enrichment of autophagy genes being differentially expressed compared to a random
set of genes in CeD biopsies (P ¼ 2.2  1016). We further showed that the SNP affecting ULK3 is also correlated with the expression levels of autophagy genes in CeD biopsies
(Supplemental Fig. 3).
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rs533646, with the risk allele G causing higher IL-6 and TNF-alphalevels (Supplemental Fig. 3). Both examples highlight the potential
functional role of lncRNAs in AID.
Fig. 3. Validation of the functional role of ULK3 locus in autophagy in celiac disease. (A) Genotype-dependent expression levels of autophagy genes in coeliac disease biopsies. There
were 3 AA, 15 AG and 13 GG genotypes. The expression for 217 autophagy genes could be extracted from the microarray data of coeliac disease biopsies and the genotype data at the
ULK3 SNP were extracted using Immunochip for 31 CeD patients. The heatmap shows the normalized expression values stratiﬁed according to the genotypes. The difference in gene
expression between AA and GG was tested by t-test and P < 0.05 was considered signiﬁcant. (B) Association of rs1378938 with interleukin 6 levels in response to lipopolysaccharide.
The CeD-associated risk allele rs1378938*T (in red) results in lowered interleukin 6 (P ¼ 0.019) cytokine levels upon LPS stimulation of primary mononuclear cells. The x-axis
displays the three different genotypes and the number of individuals in each group. The y-axis presents the age and gender corrected cytokine levels.
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genes
Although we found cis-eQTLs for 183 SNPs, they deﬁne only 120
loci (based on the 1 Mb region around the index SNPs). Among
these 120 loci, 54 loci were found shared between two or more AID
(Supplemental Table 6). In nine of the shared loci (16.7%), we found
different AID-SNPs affecting different genes. The MS and IBD
associated locus at 11q13.1 provides an illustrative example. MSSNP rs694739 affects two protein-coding genes and a lncRNA gene,
while the IBD SNP rs559928 affects a different lncRNA (Fig. 5). The
MS SNP rs694739 and its close proxies overlap with DNAse I hy-
persensitivity sites (DHSs) of many immune cells, whereas one of
the two proxies of the IBD SNP rs559928 speciﬁcally overlaps with
DHSs in Caco-2 cells (intestinal epithelial cells), suggesting that
different usage of cell-type-speciﬁc enhancers could be one
mechanism by which different genes could be affected by different
AID-SNPs in a shared disease locus.
Table 1
AID-SNPs that affect the expression levels of only non-coding RNAs.
AID SNP SNP Chr SNP Chr positiona HUGO Gene ID Gene Chr positiona Risk alleleb Directionc eQTL P
CD rs1260326 2 27730940 AC109828.1 27561937 T up 1.44  104
CD rs1260326 2 27730940 FTH1P3 27615942 T up 8.40  103
RA rs34695944 2 61124850 RP11-373L24.1 61154165 C up 7.99  108
IBD rs6708413 2 103063369 MIR4772 103048787 G down 8.01  1015
CeD rs1018326 2 182007800 AC104820.2 182115472 C up 9.22  108
AS rs12615545 2 182048452 AC104820.2 182115472 C up 5.99  108
AS rs10045403 5 96147733 CTD-2260A17.1 96121092 A down 7.89  1014
MS rs941816 6 36375304 MIR3925 36590251 G down 3.88  103
MS rs706015 7 27014988 HOTAIRM1 27137575 C up 1.51  1036
IBD rs4743820 9 93928416 RP11-305L7.1 93868412 T up 4.86  1023
PS rs10979182 9 110817020 RP11-240E2.2 110802683 A down 5.56  105
RA rs2671692 10 50097819 RP11-563N6.6 50086380 A up 3.90  104
IBD rs7097656 10 82250831 RP11-137H2.4 82292525 C down 1.41  107
MS rs694739 11 64097233 AP003774.1 64094749 A down 2.65  10130
IBD rs559928 11 64150370 AP003774.6 64162558 C up 3.21  104
UC rs561722 11 114386830 RP11-64D24.2 114154315 C down 4.55  103
MS rs533646 11 118566746 AP002954.4 118598144 G down 6.41  1080
CeD rs10892258 11 118579865 AP002954.4 118598144 G up 2.18  103
RA rs10790268 11 118729391 AP002954.4 118598144 G down 4.55  103
MS rs12296430 12 6503500 RP1-102E24.8 6503653 C up 1.01  1021
PS rs2066819 12 56750204 RP11-977G19.11 56701259 C down 2.00  103
MS rs6498184 16 11435990 RP11-485G7.5 11437367 G down 4.92  103
RA rs4780401 16 11839326 UBL5P4 12062482 T down 3.88  103
RA rs13330176 16 86019087 RP11-542M13.2 86016842 A down 6.88  104
IBD rs727088 18 67530439 RP11-543H23.2 67382212 G up 1.37  1018
PS rs892085 19 10818092 ILF3-AS1 10763529 A down 9.05  104
UC rs6017342 20 43065028 RP5-1013A22.2 43078074 C down 3.58  103
IBD rs913678 20 48955424 RP11-290F20.1 48920358 T up 7.99  108
AS rs7282490 21 45615741 AP001057.1 45621876 G down 4.29  104
IBD rs7282490 21 45615741 AP001057.1 45621876 G down 4.29  104
IBD rs2413583 22 39659773 RP4-742C19.8 39534946 C down 3.04  103
AS¼ ankylosing spondylitis, CeD¼ coeliac disease, CD¼ Crohn's disease, IBD¼ inﬂammatory bowel disease, MS¼multiple sclerosis, PS¼ psoriasis, RA¼ rheumatoid arthritis
and UC ¼ ulcerative colitis.
a All chromosomal positions are based on UCSC/hg19 coordinates.
b Risk alleles are as reported in the original publications.
c The direction of the eQTL effect by the risk allele.
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genes in cis due to extended linkage disequilibrium
About 39% of AID-SNPs (71/183 SNPs) affect the expression
levels of two or more genes (multi-gene SNPs) compared to 61%
(112/183 SNPs) that affect only a single gene (single-gene SNPs)
(Fig. 1A). We found no difference in the average number of genes
present in these loci, the allele frequencies of the SNPs, or local
patterns of co-expression of genes (Supplemental Figs. 4, 5& 6) that
could explain the differences. However, we observed signiﬁcant
differences in the size of the LD blocks (P ¼ 0.0002), with multi-
gene SNPs located within larger LD blocks (average LD block size
175 kb) than single-gene SNPs (average LD block size 100 kb)
(Fig. 6A). This suggests that multi-gene SNPs may regulate gene
expression in a larger cis-window. To test this, we extended the cis-
window to 2 Mb and repeated the cis-eQTL mapping. We observed
that 42% of multi-gene SNPs (30/71) affect genes that are located in
the extended 2 Mb cis-window compared to only 19% of single-
gene SNPs (21/112, P ¼ 0.0001; Supplemental Fig. 7), suggesting
that some AID-SNPs are located within regulatory regions that can
control the expression of multiple genes spread over long distances
in cis. In support of this we found that multi-gene SNPs regions are
enriched for super-enhancers [29] (P ¼ 0.0018) and CTCF binding
sites (Supplemental Figs. 8 and 9), which are known to mediate
chromatin looping [40,41].
3.7. Expression regulation of multiple genes in cis is partly via
chromatin looping interactions
Recent studies by others suggest that lncRNAs play a role inregulating transcription of genes over longer distances, by medi-
ating chromatin looping that brings enhancers and promoters
together [42,43]. We therefore tested whether AID-SNPs affecting
lncRNAs are involved in regulating multiple genes in cismore often
than AID-SNPs affecting only protein-coding genes. We found that
69% of AID-SNPs that impact lncRNAs are also multi-gene SNPs
(based on the 2 Mb cis-window) compared to 40% of AID-SNPs that
impact only protein-coding genes (P ¼ 0.0002; Fig. 6B), suggesting
that lncRNAs could be one of the factors in regulating the expres-
sion of multiple cis genes. To conﬁrm the observation that AID-SNPs
and lncRNAs are potentially involved in looping interactions to
regulate gene expression, we manually cross-referenced our
lncRNA-eQTLs with genome-wide RNA polymerase II (RNAPII) in-
teractions, mapped by ChIA-PET assay [31,32] in GM12878 (B-
lymphoblastoid) [33]. We found that multi-gene SNPs are more
often (64 SNPs out of 92; 70%) involved in looping interactions in B
cells (P ¼ 0.048) than single-gene SNPs (55%; Supplementary
Tables 7 and 8). Many of these loci show very strong interaction
where more than 50 independent interactions between AID SNPs
and regulatory regions of eQTL genes are found (Supplementary
Fig. 10aes). We found that for some lncRNA-eQTLs, the affected
lncRNAs and the promoters of the protein-coding genes are orga-
nized in the same transcription topological unit mediated by RNA
Polymerase II (RNAPII). For example, SNP rs6667605 at 1q32.1
associated with UC affects the levels of transcription of four genes
(MMEL1, TNFRSF14, RP3-395M20.7 and RP3-395M20.8). According to
the RNAPII ChIA-PET interaction data, we observed that SNP
rs6667605 and the lncRNAs RP3-395M20.7 and RP3-395M20.8were
interacting with the promoter region of the protein-coding gene
TNFRSF14 (Fig. 6C). All three genes are expressed in lymphoblast
Fig. 4. Examples of long non-coding RNAs as candidate causal genes for AIDs. (A) The locus on chromosome 2q32.3 is associated to AD (rs12615545) and CeD (rs1018326), and both
SNPs are in strong LD (r2 ¼ 0.96, D’ ¼ 1). The CeD-associated risk allele, rs1018326*C is associated with higher levels of expression of the AC104820.2 lncRNA (similar results were
observed for AD risk allele at rs12615545). The function prediction based on co-expression (GO biological processes) suggested this lncRNA is involved in alpha-beta T-cell pro-
liferation. The right-hand panel shows the expression pattern for AC104820.2 lncRNA across seven different immune cell types (obtained from two individuals and the average
expression levels are shown), which indicates its strong expression in CD8þ T-cells. (B) The locus on chromosome 11q23.3 is associated to CeD (rs10892258), MS (rs533646) and RA
(rs10790268). The MS-associated risk allele rs533646*G is associated with lower levels of expression of the AP002954.4 lncRNA (eQTL P ¼ 6.41  1080; similar results were also
observed for the CeD and RA risk alleles). The expression patterns across seven cell types were obtained from two individuals and the average expression levels are shown as a
heatmap, which conﬁrms the strong expression of AP002954.4 in monocytes. The function prediction based on co-expression (GO biological processes) was obtained from the RNA
network (http://genenetwork.nl/)7.
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(Supplemental Figs. 11 and 12), supporting the idea that co-
regulation of TNFRSF14 and the two lncRNAs may occur through
looping interactions.
3.8. Rheumatoid arthritis lncRNA as an example of trans-regulator
of genes enriched for B cell proliferation
Some AID-SNPs can affect the expression of multiple genes intrans [4]. We tested whether lncRNA cis-eQTLs can also be trans-
eQTLs. We observed that the RA-associated SNP rs13330176 at
16q24.1 affects levels of expression of lncRNA RP11-542M13.2 in cis,
which is predicted to be involved in B-cell proliferation
(Supplemental Fig. 13). The same SNP is also moderately associated
(P < 0.0009) with the expression level of more than ten genes in
trans (Supplemental Table 9), which are also involved in B-cell
related processes. Although our sample size is a limiting factor in
trans-eQTL mapping, this example illustrates the possibility of
Fig. 5. Shared disease loci may harbour different candidate causal genes for different AIDs. (A) The upper panel shows the regional plot of MS- (rs694739) and IBD- (rs559928)
associated SNPs at 11q13.1 that affect expression of independent genes. The DNAse H1 sites (DHSs) from different cell lines were intersected with both gSNPs and their proxies. The
gSNPs are highlighted with an oval shape around the line. DHSs of immune cells (alpha-beta T-cells, Jurkat T-cells, monocytes, naive B cells, T helper cells (Th0, Th1, Th2) and
regulatory T-cells (Treg) and Caco-2 cells (intestinal epithelial cells) were extracted from the databases of ENCODE and the Blueprint epigenome project. (B) The MS SNP rs694739
affects the expression levels of lncRNA AP003774.1 (P ¼ 2.65  10130), followed by CCDC88B (P ¼ 7.89  1014) and PPP1R14B (P ¼ 7.08  106), while IBD SNP rs559928 only weakly
affects the expression level of lncRNA AP003774.6 (P ¼ 3.21  104). The function prediction based on co-expression (GO biological processes) was obtained from the RNA network
[30]. Consistent with the DHSs pattern, the MS SNP affected genes are predicted to be involved in immune cell activation and the lncRNA affected by the IBD SNP is involved in
innate immune function. (C) The expression pattern for eQTL genes across seven different immune cell types were obtained from two individuals and the average expression levels
are shown as a heatmap.
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4. Discussion
Identiﬁcation of the correct causal genes within GWAS loci is
critical not only for the proper interpretation of associated loci but
also to pinpoint potential therapeutic targets. RNA-sequencing will
identify causal genes in an unbiased manner as it provides quan-
tiﬁcation of the global transcriptome at high resolution to efﬁ-
ciently capture all transcripts including lowly abundant transcripts
such as lncRNA genes, [23]. Our study indeed shows that eQTL
analysis based on RNA-sequencing data is a ﬁrst and important step
in delineating the complex genetic architecture of AIDs. We made
use of the currently largest available cohort of PMBC-based RNA-
sequencing data and report, for the ﬁrst time, an extensive list of 53
ncRNAs as candidate causal genes for AIDs, which highlight the
added value of RNA-sequencing over conventional microarrays.
Since lncRNA genes have shown to be more cell-type speciﬁc than
protein-coding genes [44], further eQTL analysis in disease speciﬁc
cell-types may identify additional lncRNA genes as potential causal
genes for AID.
In addition to lncRNAs, we also identiﬁed 157 cis-eQTLs on
protein coding genes, which helped us to implicate novel candidate
causal genes and pathways in several loci. We found that a SNP
associated to CeD was affecting ULK3 that encodes a kinase
involved in autophagy. By analysing intestinal biopsies of CeDpatients, we observed that ULK3 is co-regulated with genes
involved in autophagy thereby implicating a possible role of the
autophagy pathway in CeD pathogenesis that was not considered
before [35]. Another example is a shared AID locus for MS, IBD, AS
and CeD at 1q32.1 region, where our analysis identiﬁed GPR25 as a
primary causal gene. G protein-coupled receptors (GPCRs) are one
of the best-studied classes of cell surface receptors and the most
amenable group of proteins for novel small molecule drug discov-
ery. GPR35 is one such example where it emerged as a potential
therapeutic target through its association with IBD, type 2 diabetes
and coronary heart disease [45]. The newly identiﬁed GPR25 gene
could be another attractive target to exploit therapeutically since it
is associated with four different AIDs. Interestingly, both ULK3and
GPR25 did not turn out to be the genes nearest to the index SNPs
which is rather frequently the case since only in 50% of cases the
nearest gene is suggested to be the candidate causal gene
(Supplemental Table 5). This ﬁnding again highlights the impor-
tance of a more careful follow up analysis of disease associated
SNPs for the correct interpretation of associated loci.
Another important observation from this study is that in 40% of
AID-loci multiple genes may predispose to disease. In addition, by
comparing the genetics of different diseases, we show that the
associated loci for many different diseases can be physically the
same but yet different genes in these loci may affect different AIDs.
The latter may be caused by cell type speciﬁcity, as suggested by our
analysis of DNAse I hypersensitive sites. Integrating eQTL analysis
Fig. 6. The size of the LD block and lncRNAs facilitate looping interactions to regulate multiple genes in cis. (A) The size of the LD blocks between SNPs that affect single genes
(single-gene SNPs) and SNPs that affect multiple genes (multi-gene SNPs) was compared. The average size of the LD block for single-gene SNPs (100 kb) was signiﬁcantly different
from the 175 kb for multi-gene SNPs (P ¼ 0.0002). The signiﬁcant difference was tested using the Wilcoxon Rank test. (B) Mapping eQTLs for SNPs affecting lncRNA and using a 2 Mb
cis-window found 69% of the AID-SNPs that impact lncRNAs are SNPs affecting multiple genes compared to 40% of AID-SNPs that impact only protein-coding genes. (C) Ulcerative
colitis-associated SNP rs6667605 at 1q36.32 affects three genes (TNFRSF14 is a protein-coding gene, RP3-395M20.8 and RP3-395M20.7 are lncRNAs). Pink loops depict the looping
interactions mediated by RNAPII that lie between the UC-associated eQTL locus and the corresponding target genes in GM12878 (B-lymphoblastoid) cells. The peaks in the middle
panel depict the RNAPII occupancy along this locus in GM12878 cells. The bottom panel shows the expression levels of genes in this locus. Expression signals from the þ and e
strands are separated into green and blue, respectively.
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disease and techniques like ChIA-PET will be critical to eventually
unmask the cell-type speciﬁc regulatory networks for different
diseases. The ability to perform trans-eQTL mapping will facilitate
the identiﬁcation of the downstream effects of disease SNPs. In
particular the further understanding of lncRNAs will beneﬁt from
such investigations. In this studywe focused on the identiﬁcation of
cis-eQTLs because our sample size had limited power for trans-
eQTL mapping. Since the majority of the GWAS SNPs regulate gene-
expression, our systematic approach of conditional eQTL mapping
and cell-type speciﬁc expression characterization of candidate
causal genes for autoimmune diseases could be efﬁcient strategy to
identify novel causal genes for other complex diseases. We antici-
pate that our study will facilitate the understanding of lncRNA-
mediated cis gene expression regulation in AID loci and
encourage further studies with bigger sample size to identify the
downstream consequences of AID-SNPs on lncRNAs.
Disclosure statement
The authors declare no competing interests.
Acknowledgements
We thank Jackie Senior and Kate Mc Intyre for editing the
manuscript. This work was supported by a European Research
Council Advanced Grant (FP/2007e2013/ERC grant 2012-322698 to
CW), the Dutch Digestive Diseases Foundation (MLDS WO11-30 to
CWand VK), the European Union's Seventh Framework Programme
(EU FP7) TANDEM project (HEALTH-F3-2012-305279 to CW and
VK), the Netherlands Organization for Scientiﬁc Research (NWO
VENI grant 916-10135 and NWO VIDI grant 917e14374 to LF; NWO
VENI grant 863.13.011 to YL), and by the Dutch Multiple Sclerosis
Foundation (grant 11-752 to SW). This work was performed within
the framework of the Biobank-Based Integrative Omics Studies
(BIOS) Consortium funded by BBMRI-NL, a research infrastructure
ﬁnanced by the Dutch government (NWO 184.021.007). Samples
were contributed by LifeLines (http://lifelines.nl/lifelines-research/
general), the Leiden Longevity Study (http://www.healthy-ageing.
nl; http://www.leidenlangleven.nl), the Rotterdam studies (http://
www.erasmus-epidemiology.nl/rotterdamstudy) and the CODAM
study (http://www.carimmaastricht.nl). We thank the participants
of all aforementioned biobanks and acknowledge the contributions
of the investigators to this study. This work was carried out on the
Dutch national e-infrastructure with the support of SURF Cooper-
ative and the Groningen Center for Information Technology
(Strikwerda, W. Albers, R. Teeninga, H. Gankema and H. Wind) and
Target storage (E. Valentyn and R. Williams). Target is supported by
Samenwerkingsverband Noord Nederland, the European Fund for
Regional Development, the Dutch Ministry of Economic Affairs,
Pieken in de Delta and the provinces of Groningen and Drenthe.”
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jaut.2016.01.002.
References
[1] D. Welter, J. MacArthur, J. Morales, T. Burdett, P. Hall, H. Junkins, et al., The
NHGRI GWAS Catalog, a curated resource of SNP-trait associations, Nucleic
Acids Res. 42 (2014) D1001eD1006.
[2] I. Ricano-Ponce, C. Wijmenga, Mapping of Immune-mediated Disease Genes.
Annual Review of Genomics and Human Genetics, 2013.
[3] V. Kumar, C. Wijmenga, R.J. Xavier, Genetics of immune-mediated disorders:
from genome-wide association to molecular mechanism, Curr. Opin.Immunol. 31C (2014) 51e57.
[4] H.J. Westra, M.J. Peters, T. Esko, H. Yaghootkar, C. Schurmann, J. Kettunen, et
al., Systematic identiﬁcation of trans eQTLs as putative drivers of known
disease associations, Nat. Genet. 45 (2013) 1238e1243.
[5] J. Harrow, A. Frankish, J.M. Gonzalez, E. Tapanari, M. Diekhans, F. Kokocinski,
et al., GENCODE: the reference human genome annotation for The ENCODE
Project, Genome Res. 22 (2012) 1760e1774.
[6] V. Kumar, H.J. Westra, J. Karjalainen, D.V. Zhernakova, T. Esko, B. Hrdlickova, et
al., Human disease-associated genetic variation impacts large intergenic non-
coding RNA expression, PLoS Genet. 9 (2013) e1003201.
[7] S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, D. Bender, et al.,
PLINK: a tool set for whole-genome association and population-based linkage
analyses, Am. J. Hum. Genet. 81 (2007) 559e575.
[8] J.B. Richards, F. Rivadeneira, M. Inouye, T.M. Pastinen, N. Soranzo, S.G. Wilson,
et al., Bone mineral density, osteoporosis, and osteoporotic fractures: a
genome-wide association study, Lancet 371 (2008) 1505e1512.
[9] D.I. Boomsma, C. Wijmenga, E.P. Slagboom, M.A. Swertz, L.C. Karssen,
A. Abdellaoui, et al., The Genome of the Netherlands: design, and project goals,
Eur. J. Hum. Genet. EJHG 22 (2014) 221e227.
[10] P. Deelen, A. Menelaou, E.M. van Leeuwen, A. Kanterakis, F. van Dijk,
C. Medina-Gomez, et al., Improved imputation quality of low-frequency and
rare variants in European samples using the ‘Genome of The Netherlands’,
Eur. J. Hum. Genet. EJHG 22 (2014) 1321e1326.
[11] Whole-genome sequence variation, population structure and demographic
history of the Dutch population, Nat. Genet. 46 (2014) 818e825.
[12] O. Delaneau, J. Marchini, J.F. Zagury, A linear complexity phasing method for
thousands of genomes, Nat. methods 9 (2012) 179e181.
[13] P. Deelen, M.J. Bonder, K.J. van der Velde, H.J. Westra, E. Winder,
D. Hendriksen, et al., Genotype harmonizer: automatic strand alignment and
format conversion for genotype data integration, BMC Res. Notes 7 (2014)
901.
[14] B.N. Howie, P. Donnelly, J. Marchini, A ﬂexible and accurate genotype impu-
tation method for the next generation of genome-wide association studies,
PLoS Genet. 5 (2009) e1000529.
[15] H. Byelas, M. Dijkstra, P.B.T. Neerincx, F. van Dijk, A. Kanterakis, P. Deelen, et
al., Scaling bio-analyses from computational clusters to grids, in: Proceedings
of the 5th International Workshop on Science Gateways, Zurich, Switzerland,
3e5 June, 2013, CEUR-WS.org, 2013.
[16] A. Dobin, C.A. Davis, F. Schlesinger, J. Drenkow, C. Zaleski, S. Jha, et al., STAR:
ultrafast universal RNA-seq aligner, Bioinformatics 29 (2013) 15e21.
[17] S. Anders, P.T. Pyl, W. Huber, HTSeq e a Python framework to work with high-
throughput sequencing data, Bioinformatics 31 (2014) 166e169.
[18] M.D. Robinson, A. Oshlack, A scaling normalization method for differential
expression analysis of RNA-seq data, Genome Biol. 11 (2010) R25.
[19] R.S. Fehrmann, R.C. Jansen, J.H. Veldink, H.J. Westra, D. Arends, M.J. Bonder, et
al., Trans-eQTLs reveal that independent genetic variants associated with a
complex phenotype converge on intermediate genes, with a major role for the
HLA, PLoS Genet. 7 (2011) e1002197.
[20] P. Deelen, D. Zhernakova, M. de Haan, M. van der Sijde, M.J. Bonder,
J. Karjalainen, et al., Calling genotypes from public RNA-sequencing data en-
ables identiﬁcation of genetic variants that affect gene-expression levels,
2014.
[21] D.V. Zhernakova, E. de Klerk, H.J. Westra, A. Mastrokolias, S. Amini,
Y. Ariyurek, et al., DeepSAGE reveals genetic variants associated with alter-
native polyadenylation and expression of coding and non-coding transcripts,
PLoS Genet. 9 (2013) e1003594.
[22] A.R. Quinlan, I.M. Hall, BEDTools: a ﬂexible suite of utilities for comparing
genomic features, Bioinformatics 26 (2010) 841e842.
[23] B. Hrdlickova, V. Kumar, K. Kanduri, D.V. Zhernakova, S. Tripathi,
J. Karjalainen, et al., Expression proﬁles of long non-coding RNAs located in
autoimmune disease-associated regions reveal immune cell-type speciﬁcity,
Genome Med. 6 (2014) 88.
[24] R. Almeida, I. Ricano-Ponce, V. Kumar, P. Deelen, A. Szperl, G. Trynka, et al.,
Fine mapping of the celiac disease-associated LPP locus reveals a potential
functional variant, Hum. Mol. Genet. 23 (2014) 2481e2489.
[25] B. Diosdado, M.C. Wapenaar, L. Franke, K.J. Duran, M.J. Goerres, M. Hadithi, et
al., A microarray screen for novel candidate genes in coeliac disease patho-
genesis, Gut 53 (2004) 944e951.
[26] G. Trynka, K.A. Hunt, N.A. Bockett, J. Romanos, V. Mistry, A. Szperl, et al., Dense
genotyping identiﬁes and localizes multiple common and rare variant asso-
ciation signals in celiac disease, Nat. Genet. 43 (2011) 1193e1201.
[27] S.P. Smeekens, A. Ng, V. Kumar, M.D. Johnson, T.S. Plantinga, C. van Diemen, et
al., Functional genomics identiﬁes type I interferon pathway as central for
host defense against Candida albicans, Nat. Commun. 4 (2013) 1342.
[28] V. Kumar, S.C. Cheng, M.D. Johnson, S.P. Smeekens, A. Wojtowicz,
E. Giamarellos-Bourboulis, et al., Immunochip SNP array identiﬁes novel ge-
netic variants conferring susceptibility to candidaemia, Nat. Commun. 5
(2014) 4675.
[29] D. Hnisz, B.J. Abraham, T.I. Lee, A. Lau, V. Saint-Andre, A.A. Sigova, et al., Super-
enhancers in the control of cell identity and disease, Cell 155 (2013) 934e947.
[30] R.S. Fehrmann, J.M. Karjalainen, M. Krajewska, H.J. Westra, D. Maloney,
A. Simeonov, et al., Gene expression analysis identiﬁes global gene dosage
sensitivity in cancer, Nat. Genet. 47 (2015) 115e125.
[31] M.J. Fullwood, M.H. Liu, Y.F. Pan, J. Liu, H. Xu, Y.B. Mohamed, et al., An
oestrogen-receptor-alpha-bound human chromatin interactome, Nature 462
I. Rica~no-Ponce et al. / Journal of Autoimmunity 68 (2016) 62e7474(2009) 58e64.
[32] G. Li, X. Ruan, R.K. Auerbach, K.S. Sandhu, M. Zheng, P. Wang, et al., Extensive
promoter-centered chromatin interactions provide a topological basis for
transcription regulation, Cell 148 (2012) 84e98.
[33] Z. Tang, O.J. Luo, X. Li, M. Zheng, J.J. Zhu, P. Szalaj, et al., CTCF-mediated human
3D genome architecture reveals chromatin topology for transcription, Cell 163
(2015) 1611e1627.
[34] M.A. Rivas, M. Beaudoin, A. Gardet, C. Stevens, Y. Sharma, C.K. Zhang, et al.,
Deep resequencing of GWAS loci identiﬁes independent rare variants asso-
ciated with inﬂammatory bowel disease, Nat. Genet. 43 (2011) 1066e1073.
[35] V. Kumar, J. Gutierrez-Achury, K. Kanduri, R. Almeida, B. Hrdlickova,
D.V. Zhernakova, et al., Systematic annotation of celiac disease loci reﬁnes
pathological pathways and suggests a genetic explanation for increased
interferon-gamma levels, Hum. Mol. Genet. 24 (2014) 397e409.
[36] N. Manjarrez-Orduno, E. Marasco, S.A. Chung, M.S. Katz, J.F. Kiridly,
K.R. Simpfendorfer, et al., CSK regulatory polymorphism is associated with
systemic lupus erythematosus and inﬂuences B-cell signaling and activation,
Nat. Genet. 44 (2012) 1227e1230.
[37] A.R. Young, M. Narita, M. Ferreira, K. Kirschner, M. Sadaie, J.F. Darot, et al.,
Autophagy mediates the mitotic senescence transition, Genes Dev. 23 (2009)
798e803.
[38] A. Han, E.W. Newell, J. Glanville, N. Fernandez-Becker, C. Khosla, Y.H. Chien, et
al., Dietary gluten triggers concomitant activation of CD4þ and CD8þ alpha-
beta T cells and gammadelta T cells in celiac disease, Proc. Natl. Acad. Sci. U. S.
A. 110 (2013) 13073e13078.
[39] L. Plaza-Izurieta, N. Fernandez-Jimenez, I. Irastorza, A. Jauregi-Miguel,
I. Romero-Garmendia, J.C. Vitoria, et al., Expression analysis in intestinal
mucosa reveals complex relations among genes under the association peaks
in celiac disease, Eur. J. Hum. Genet. EJHG 23 (2014) 1100e1105.[40] S.S. Rao, M.H. Huntley, N.C. Durand, E.K. Stamenova, I.D. Bochkov,
J.T. Robinson, et al., A 3D map of the human genome at kilobase resolution
reveals principles of chromatin looping, Cell 159 (2014) 1665e1680.
[41] P. Majumder, J.A. Gomez, B.P. Chadwick, J.M. Boss, The insulator factor CTCF
controls MHC class II gene expression and is required for the formation of
long-distance chromatin interactions, J. Exp. Med. 205 (2008) 785e798.
[42] F. Lai, U.A. Orom, M. Cesaroni, M. Beringer, D.J. Taatjes, G.A. Blobel, et al.,
Activating RNAs associate with Mediator to enhance chromatin architecture
and transcription, Nature 494 (2013) 497e501.
[43] S. Quinodoz, M. Guttman, Long noncoding RNAs: an emerging link between
gene regulation and nuclear organization, Trends Cell Biol. 24 (2014)
651e663.
[44] M.N. Cabili, C. Trapnell, L. Goff, M. Koziol, B. Tazon-Vega, A. Regev, et al.,
Integrative annotation of human large intergenic noncoding RNAs reveals
global properties and speciﬁc subclasses, Genes Dev. 25 (2011) 1915e1927.
[45] N. Divorty, A.E. Mackenzie, S.A. Nicklin, G. Milligan, G protein-coupled re-
ceptor 35: an emerging target in inﬂammatory and cardiovascular disease,
Front. Pharmacol. 6 (2015) 41.URLs
[46] UCSC genome browser; http://genome-euro.ucsc.edu/index.html.
[47] RNAseq data downloaded from public databases; https://www.ebi.ac.uk/
arrayexpress/.
[48] Access to RNA network; http://genenetwork.nl/wordpress/.
[49] Access to Genotype Harmonizer; http://www.molgenis.org/systemsgenetics/.
[50] Human Autophagy Database; http://autophagy.lu/clustering/index.html.
